True Wealth Design, LLC Celldex Therapeutics, Inc. Transaction History
True Wealth Design, LLC
- $327 Billion
- Q3 2025
A detailed history of True Wealth Design, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 11 shares of CLDX stock, worth $268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 11
-0.0%
Holding current value
$268
Previous $224,000
27.23%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
207Shares Held
68.5MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$149 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$128 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.95MShares$96.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$93 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.14B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...